Navigation Links
Civil Rights and Medical Leaders Call for Social Justice in Health Care
Date:9/27/2007

is built upon a foundation of health equity".

The National Minority Quality Forum is a not-for-profit, non-partisan organization dedicated to research, education, and advocacy to assure the availability of quality health services for all Americans.

(1) Executive Director, National Medical Association

(2) Delegate, U.S. Virgin Islands, U.S. House of Representatives

(3) Founder and President, National Pastors Network

(4) President, Association of Black Cardiologists

(5) Founder and President, Rainbow/PUSH Coalition

(6) Chief of Cardiology, Morehouse School of Medicine

(7) Founder and President, National Action Network

(8) National President and CEO, Southern Christian Leadership Conference

(9) Director, Washington Bureau, NAACP

(10) Board Chair, Institute for the Advancement of Multicultural and

Minority Medicine


'/>"/>
SOURCE National Minority Quality Forum
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships
2. Health Minister-Gujarat Rushed To Civil Hospital
3. Lack of Equipment and Skilled Doctors Costing Civilian Lives in Iraq
4. Pakistan civil servants may retire at 62
5. India-Born Dr Death Faces Civil Suits
6. Various Civil Society Groups Form Alliance to Fight HIV/AIDS
7. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
8. Equal Rights for HIV Infected Workers
9. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
10. HIV Carriers Join Hands to Fight for their Rights
11. Need for Legal Rights to Birth Parents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2008)... Articles on Breast Cancer and Shopping,Offers Ben...t. 7 /PRNewswire-FirstCall/ -- BOOMj, Inc. (OTC,Bu...ading social networking,community for Baby Boomers... commitment to supporting all those touched by bre...in/prnh/20070131/BOOMJLOGO ), Every day in Octob...
(Date:10/7/2008)... More Than 20 Pink Products All,Year Long With a P...r the,Cure(R) at HelpHopeBloom.com, SAN DIEGO, Oc...,awareness and help the fight against breast cance...he Cure Pink Ribbon Collection. Launched in 2001,...year-round and includes,Pink Ribbon Tulips, the Pi...
(Date:10/7/2008)...-- Viant, Inc. today announced,that the company ha...caid,Services (CMS) that it was not selected to se... rollout of the Medicare Recovery Auditing,Contrac...t contracts were,awarded in the four RAC regions t... CMS,s minimum technical requirements, with no sin...
(Date:10/7/2008)...3OOO Group, Inc. (MED3OOO), a,national leader in h...ervices for providers and employers, recently appo...liance and Ethics Officer. Ms. Hoffman has 29,year...10 years in,healthcare compliance and risk managem...le for the oversight of,MED3OOO,s corporate compli...
Breaking Medicine News(10 mins):Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 2Health News:BOOMj, Inc. Joins Fight Against Breast Cancer 3Health News:Breast Cancer Awareness Blooms in October With ProFlowers 2Health News:Breast Cancer Awareness Blooms in October With ProFlowers 3Health News:MED3OOO Appoints Angela Hoffman as Chief Compliance Officer 2
...ew study shows that infants born under 5.5 pounds ...k for developing // type 2 diabetes later in life....trition isn't the only cause of prenatal malnouris...nta and its blood vessels and high blood pressure,...
...ording to a recent study researchers say, Monteluk...es mediate inflammation // in the body and play a ...f asthma in young children by about 32 percent whi...searchers conducted a one-year study involving 549...
... had urged the people to be prepared for any outbr...Although the //disease mainly spreads from birds t...ptical that the strain of virus that causes bird f...ad the disease human to human, and cause an influe...
...tiapine, a drug used to treat agitation in patient...n cognitive decline say researchers based on findi...g home patients were observed . Twenty-six of the ...chotic also known as Seroquel), 25 received rivast...
Other Medicine News:
(Date:10/6/2008)...or to the understanding of and possible t..., BILLERICA, Mass., Oct. 6 /- Seahor...irst ever analytical instrument for the,kinetic me...cytoplasmic,glycolysis in cells in a 96 well micro...ellular bioenergetics have been relatively unchang...
(Date:10/6/2008)...s with Durezol Dosed Prior to Surgery, TAMPA, Fla...., a,privately held ophthalmic-focused biopharmace...difluprednate ophthalmic emulsion) 0.05% is now,co...by the U.S. Food and,Drug Administration in June 2...ted for the treatment of inflammation and pain ass...
(Date:10/6/2008)...heduled for 9:00 AM ET Today -, SEATTLE, Oct. 6 /...daq:,DNDN) announced today that it has completed t...ized, double-blind, placebo-controlled IMPACT,(IMm...also known as D9902B),clinical trial designed to a...al active cellular immunotherapy PROVENGE(R) (sipu...
(Date:10/6/2008)...inking polyphenol-rich 100% Concord grape,juice wa...intake or body,weight, CONCORD, Mass., Oct. 6 /PR...l-rich Concord grape juice did not cause significa... appetite and was shown to reduce waist,circumfere...nual Meeting of,the American College of Nutrition ...
Breaking Medicine Technology:Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 1China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 2China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 3China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA 1943 4Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 1Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 2Signalife Receives FDA Clearance for OTC Non Prescription Event Recorder Device 1941 3Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference 1939 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 1Bio advancements Expected to Drive Burn Care Market Growth Up 24700 Million 1937 2
...IRE) -- July 02, 2007 -- DOR BioPharma, Inc.,(OTCB...that the,first results from testing of a multivale...ade;, have been published in the journal,Infection...n and,Immunity, v. 75, p. 3043 ). These results ar...elicited by a multivalent vaccine,that is active b...
...o Timeline for Second Pivotal Phase 3 Trial CL-05,...Advanced Life,Sciences Holdings, Inc. , today anno...ta from Trial CL-06, the first of two,pivotal Phas...and,effectiveness of cethromycin, a novel once-a-d...ired pneumonia (CAP). The Company,also provided an...
Other Medicine Technology:DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
New Image Drainable Pouch, Ultra-Clear without Filter
New Image Drainable Mini-Pouch, Beige
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange, with Tape
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
Medicine Products: